Quality & complianceOfficial

Infarmed orders recall of Entecavir Viatris batches over active substance manufacturing concerns

🇵🇹 INFARMED · Thu 19 Nov 2026

Portugal's medicines authority has halted distribution of the listed batches after a counterpart regulator found active substance manufacturing issues linked to potential contamination and cross-contamination.

Infarmed, Portugal's medicines regulator, has ordered the recall of Entecavir Viatris medicines and the immediate suspension of distribution of the batches listed in an annex to Circular Informativa n.º 108/CD/550.20.001, dated 19 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: INFARMED ↗

Article written by VigiEye from the official source (INFARMED). AI-assisted; check the source before acting.